Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Timothy Fitzgerald (Author), Maryia Zhdanava (Author), Dominic Pilon (Author), Aditi Shah (Author), Patrick Lefebvre (Author), Steven R. Feldman (Author)
Hōputu:	Pukapuka
I whakaputaina:	Adis, Springer Healthcare, 2023-09-01T00:00:00Z.
Ngā marau:	article
Urunga tuihono:	Connect to this object online.
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ipurangi

Ngā taipitopito puringa mai i 3rd Floor Main Library
Tau karanga:	A1234.567
Tārua 1	Wātea